Cancer Vaccination and Challenges

Rishabha Malviya, PhD, has 11 years of research experience and is presently working as Associate Professor in the Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University, Greater Noida, Uttar Pradesh, India. His areas of interest include formulation optimization, nanoformulation, targeted drug delivery, localized drug delivery, and characterization of natural polymers as pharmaceutical excipients. He has authored more than 150 research and review papers for national and international journals of repute. He holds over 50 patents and has published many papers in reputed national and international journals, for which he received an outstanding reviewer award from Elsevier. He has edited 13 books (Wiley, Springer Nature, CRC Press/Taylor and Francis, Apple Academic Press, River Publisher, Lambert, and OMICS Publishing Group) and authored 15 book chapters. His name has been included in the World’s Top 2% Scientists list by Elsevier BV and Stanford University. He is reviewer, editor, and editorial board member of more than 50 national and international journals. He was an invited author for the magazine Atlas of Science as well as a pharma magazine dealing with B2B industry, Ingredient South Asia. He completed his BPharm at Uttar Pradesh Technical University and MPharm (Pharmaceutics) at Gautam Buddha Technical University, Lucknow, Uttar Pradesh. His PhD (Pharmacy) work was in novel formulation development techniques. Bhupendra Prajapati, PhD, is a Professor in the Department of Pharmaceutics, Shree S. K. Patel College of Pharmaceutical Education and Research, Ganpat University, Gujarat, India. He has more than 20 years of academic and research experience and has published more than 100 research and review papers in international and national journals. He has edited three books and has authored 20 book chapters in the field of novel drug delivery. He has published two Indian patents and has three applications under evaluation. He is a reviewer for three high impact journals and is on the editorial boards of several scientific journals.Sonali Sundram, PhD, is Assistant Professor in the School of Medical & Allied Sciences at Galgotias University, Greater Noida, Uttar Pradesh, India. Previously, she worked as a research scientist on a project of ICMR at King George’s Medical University, Lucknow, India. After that, she joined BBDNIIT (Babu Banarasi Das Northern India Institute of Technology), Lucknow. Her PhD (Pharmacy) work was in neurodegeneration and nanoformulation. Her areas of interest include neurodegeneration, clinical research, and artificial intelligence. She has edited four books (Wiley, CRC Press/Taylor and Francis, River Publisher) and has organized more than 15 national and international seminars, conferences, and workshops. She has more than eight patents, both national and international, to her credit. She completed both BPharm and MPharm (Pharmacology) from Dr. A.P.J. Abdul Kalam Technical University, Lucknow, India.

“A comprehensive guide to cancer vaccine research. . . . cover[s] every aspect of cancer immunology and vaccine development . . . and explores the most successful and promising approaches by incorporating the latest studies on preventive and therapeutic cancer vaccination. The book offers up-to-date information on various topics, including tumor antigens for cancer vaccines, strategies, approaches, advancements, difficulties, and challenges in vaccine development for cancer treatment. Recent advances in DNA and RNA-based vaccines for cancer prevention and treatment are thoroughly discussed in this volume. This compendium enables researchers and practitioners to easily access the comprehensive concept of cancer vaccines and their implications in healthcare. . . . An essential resource in disseminating the vast and expanding literature on cancer immunization and vaccine development.” —From the Foreword by Harish Padh, Former Vice-Chancellor, Sardar Patel University, Vallabh Vidyanagar, Anand, Gujarat, India; Former Director, B. V. Patel Pharmaceutical Education and Research Development (PERD), Ahmedabad, Gujarat, India

• VOLUME 1: DIFFERENT STRATEGIES FOR THERAPEUTIC CANCER VACCINE DEVELOPMENT 1. Cancer Vaccines: Types, Mechanisms, and Recent Developments 2. Strategies to Develop Cancer Vaccines 3. Role of Tumor Antigens for Cancer Vaccine Development 4. DNA-Based Cancer Vaccine: Advancements and Challenges 5. RNA-Based Cancer Vaccines: Advancements and Challenges 6. Utilization of Microbial Genes as a Vaccine Against Cancer 7. Utilization of Protein and Peptides as Cancer Vaccines: Advancements and Challenges 8. Stem Cell-Based Cancer Vaccines as Promising Immunotherapy: Current Progress and Challenges 9. Preventive Cancer Vaccines 10. Providing Cognitive Platforms for the Effectiveness of Cancer Vaccines 11. Survival Data and Therapeutic Outcomes of Cancer Vaccines 12. Regulatory Considerations for Cancer Vaccines Development VOLUME 2: DELIVERY STRATEGIES FOR CANCER VACCINES AND IMMUNOTHERAPY IN THE MANAGEMENT OF VARIOUS CARCINOMAS 1. Delivery Systems for Cancer Vaccines 2. Current Knowledge and Prospects of Various Vaccine Delivery Systems for Lung Cancer Treatment 3. Advanced Drug Delivery System for Targeting Carcinomas 4. Correlation Between Cancer Vaccines and Immunity 5. Cancer Vaccines for Lung Cancer 6. Synergistic Effect of Vaccines and Chemotherapeutic Agents in Combating Different Carcinomas 7. Cancer Immunotherapy Using mRNA 8. Autologous Vaccines for Prostate and Pancreatic Cancer 9. Combined Therapy of Cancer with Vaccines and Chemotherapeutic Agents 10. Role of Various Cancer Vaccine Adjuvants in Cancer Management 11. Combined Therapy of Cancer with Vaccines and Chemotherapeutic Agents